Strongest Families (Formerly Family Help Program): Pediatric Anxiety
The purpose of the Strongest Families (formerly Family Help Program)is to evaluate the effectiveness of the Strongest Families distance intervention compared to usual or standard care that is typically provided to children with mild to moderate Anxiety symptomology. This is a single-center trial based at the IWK Health Center. The primary outcome is change in diagnosis...
Brief Summary
Official Title: “Strongest Families (Formerly Family Help Program): Primary Care Delivery by Telephone for Psychological and Behavioural Problems (Pediatric Anxiety)”
The purpose of the Strongest Families (formerly Family Help Program)is to evaluate the effectiveness of the Strongest Families distance intervention compared to usual or standard care that is typically provided to children with mild to moderate Anxiety symptomology. This is a single-center trial based at the IWK Health Center. The primary outcome is change in diagnosis.
- Study Type: Interventional
- Study Design: Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Treatment
- Study Primary Completion Date: September 2007
Detailed Clinical Trial Description
The purpose of the Strongest Families (formerly Family Help Program)is to deliver, primary care mental health services to children and their families in the comfort and privacy of their own home. Approximately 128 children (6-12 years of age)suffering from mild to moderate (but clinically significant) symptoms of pediatric anxiety will be randomized.
The intervention is delivered from a distance, using educational materials (manuals, video-tapes, audio-tapes) and telephone consultation with a trained paraprofessional "coach" who is supervised by a licensed health care professional. The telephone coach delivers consistent care based on written protocols, with on-going evaluation by a professional team.
Fifty percent of the eligible participants will receive Strongest Families (formerly Family Help Program) telephone-based treatment and 50% will be referred back to their family physician to receive standard care as determined by that physician. Those receiving standard care will be evaluated for outcome results and then compared to the Family Help treated participants. It is anticipated that Family Help treatment will be proven to be as or more effective than standard care.
Intervention(s) in this Clinical Trial
- Behavioral: Strongest Families (formerly Family Help Program): Anxiety Program
- Evidence-based psychological and behavioural distance intervention
Arms, Groups and Cohorts in this Clinical Trial
- Experimental: Treatment
- 50% random assignment to receive Family Help Anxiety Treatment
- Experimental: Control
- 50% random assignment to control group to receive usual/standard care for anxiety
Outcome Measures for this Clinical Trial
Primary Measures
- Diagnosis using KSADS
- Time Frame: baseline, 120, 240 and 365 day follow-up.
Safety Issue?: No
- Time Frame: baseline, 120, 240 and 365 day follow-up.
Secondary Measures
- Symptomology frequency as evidenced by diary data;
- Time Frame: daily during treatment; 3 weeks on follow-up at 240 & 365 day post randomization
Safety Issue?: No
- Time Frame: daily during treatment; 3 weeks on follow-up at 240 & 365 day post randomization
- Anxiety specific measure (MASC- self-report);
- Time Frame: baseline, 120, 240 and 365 day follow-up
Safety Issue?: No
- Time Frame: baseline, 120, 240 and 365 day follow-up
- Disability Measure;
- Time Frame: weekly during treatment; baseline, 120, 240 and 365 day follow-up
Safety Issue?: No
- Time Frame: weekly during treatment; baseline, 120, 240 and 365 day follow-up
- Child Health Questionnaire
- Time Frame: baseline, 120, 240 and 365 day follow-up
Safety Issue?: No
- Time Frame: baseline, 120, 240 and 365 day follow-up
- Economic Outcome assessment
- Time Frame: baseline, 120, 240 and 365 day follow-up
Safety Issue?: No
- Time Frame: baseline, 120, 240 and 365 day follow-up
Criteria for Participation in this Clinical Trial
Inclusion Criteria:
- child 6 to 12 years of age
- child had Anxiety symptoms for 6 months or longer
- access to a telephone in the home
- speak and write english
- mild to moderate anxiety symptomology
Exclusion Criteria:
- severe anxiety symptomology
- received similar intervention within past 6 months
- excessive anxiety following a significant traumatic event
Gender Eligibility for this Clinical Trial: Both
Minimum Age for this Clinical Trial: 6 Years
Maximum Age for this Clinical Trial: 12 Years
Are Healthy Volunteers Accepted for this Clinical Trial?: Accepts Healthy Volunteers
Clinical Trial Investigator Information
Lead Investigator: IWK Health Centre Other
Overall Clinical Trial Officials and Contacts
Patrick J McGrath, PhD. Principal Investigator IWK Health Centre
Related Publications
References
Lingely-Pottie P, McGrath PJ. A therapeutic alliance can exist without face-to-face contact. J Telemed Telecare. 2006;12(8):396-9.
Lingley-Pottie P, McGrath PJ. Telehealth: a child and family-friendly approach to mental health-care reform. J Telemed Telecare. 2008;14(5):225-6.
Lingley-Pottie P, McGrath PJ. Distance therapeutic alliance: the participant's experience. ANS Adv Nurs Sci. 2007 Oct-Dec;30(4):353-66.
McGrath PJ, Lingley-Pottie P, Emberly DJ, Thurston C, McLean C. Integrated knowledge translation in mental health: family help as an example. J Can Acad Child Adolesc Psychiatry. 2009 Feb;18(1):30-7.
Citations Reporting Results
Lingley-Pottie P, McGrath PJ. A paediatric therapeutic alliance occurs with distance intervention. J Telemed Telecare. 2008;14(5):236-40.
Additional Information
Information obtained from ClinicalTrials.gov on February 09, 2012
Link to the current ClinicalTrials.gov record. http://clinicaltrials.gov/show/NCT00267566
Study ID Number: 2234a
ClinicalTrials.gov Identifier: NCT00267566
Health Authority: Canada: Canadian Institutes of Health Research
Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.
The URL of this page is:
http://clinicaltrialsfeeds.org/clinical-trials/show/NCT00267566
